EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Revisiting butyrylcholinesterase in Alzheimer's disease: A hub linking cholinergic, metabolic and affective pathways

Barbora Svobodova, Ondrej Soukup, Jan Korabecny

Ageing Research Reviews · 2026-07 · 119 · 103187

DOI: 10.1016/j.arr.2026.103187 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-07. Verfasst von Barbora Svobodova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove 500 05, Czech Republic. Hauptthemen laut MEDLINE: Alzheimer Disease, Butyrylcholinesterase, Cholinesterase Inhibitors, Affect. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Gefördert von: University Hospital Hradec Kralove, Univerzita Obrany.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Selective butyrylcholinesterase (BChE) inhibition is gaining renewed attention as a potential therapeutic strategy for Alzheimer's disease (AD), particularly in advanced stages marked by a shift from acetylcholinesterase (AChE) to BChE dominance. Beyond cholinergic regulation, BChE participates in metabolic, inflammatory, and affective pathways, including the enzymatic control of acyl ghrelin that influences appetite, energy balance, and mood. Preclinical and experimental evidence suggests that selective BChE inhibition may modulate cholinergic tone, enhance cognition, and exert antidepressant- and anti-anhedonic-like effects, although clinical evidence remains limited and inconclusive. Genetic polymorphisms in BChE further shape disease progression and responses to cholinesterase therapy. This review integrates advances in BChE inhibitor development with evolving insights into BChE-dependent metabolic and neuropsychiatric mechanisms, highlighting selective BChE inhibition as a multifaceted therapeutic approach in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseButyrylcholinesteraseCholinesterase InhibitorsAffectHumansAnimalsGhrelin

Stichwörter der Autor:innen

Alzheimer's diseaseButyrylcholinesteraseDepressionGhrelinMalnutrition

Substanzen

ButyrylcholinesteraseCholinesterase InhibitorsGhrelin

Autor:innen und Institutionen

  • Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove 500 05, Czech Republic.
  • Biomedical Research Centre, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove 500 05, Czech Republic; Department of Toxicology and Military Pharmacy, Military Faculty of Medicine, University of Defence, T…

Förderung

  • University Hospital Hradec Kralove
  • Univerzita Obrany

Zitieren

APA

Svobodova, B., Soukup, O., & Korabecny, J. (2026). Revisiting butyrylcholinesterase in Alzheimer's disease: A hub linking cholinergic, metabolic and affective pathways. Ageing Research Reviews, 119, 103187. https://doi.org/10.1016/j.arr.2026.103187

Vancouver

Svobodova B, Soukup O, Korabecny J. Revisiting butyrylcholinesterase in Alzheimer's disease: A hub linking cholinergic, metabolic and affective pathways. Ageing Research Reviews. 2026;119:103187. doi:10.1016/j.arr.2026.103187

BibTeX
@article{Svobodova2026,
  author = {Svobodova, Barbora and Soukup, Ondrej and Korabecny, Jan},
  title = {Revisiting butyrylcholinesterase in Alzheimer's disease: A hub linking cholinergic, metabolic and affective pathways},
  journal = {Ageing Research Reviews},
  year = {2026},
  volume = {119},
  pages = {103187},
  doi = {10.1016/j.arr.2026.103187}
}
Kostenlos starten →